Exact Mass: 452.2116
Exact Mass Matches: 452.2116
Found 500 metabolites which its exact mass value is equals to given mass value 452.2116
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
3b,12b-Etheno-4H-cyclopenta(1,2)phenanthro(9,10-c)furan-1,3-dione, 10-acetyl-5-(acetyloxy)-3a,5,6,7,7a,9,9a,10,11,12,12a,12c-dodecahydro-7a,9a-dimethyl-
8-Butanoylneosolaniol
8-Butanoylneosolaniol is produced by Fusarium sporotrichioides.
8-Isobutanoylneosolaniol
8-Isobutanoylneosolaniol is produced by Fusarium sporotrichioides. Production by Fusarium sporotrichioides
(S)-3-(8-(Dimethylaminomethyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-3-indolyl)-1H-pyrrole-2,5-dione hydrochloride
2'-Methoxykurarinone
(2S)-2-methoxykurarinone is a dimethoxyflavanone that is (2S)-(-)-kurarinone in which the hydroxy group at position 2 is replaced by a methoxy group. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity against human myeloid leukemia HL-60 cells. It has a role as a metabolite and an antineoplastic agent. It is a dimethoxyflavanone, a dihydroxyflavanone and a member of 4-hydroxyflavanones. It is functionally related to a (2S)-(-)-kurarinone. (2S)-2-methoxykurarinone is a natural product found in Sophora flavescens with data available. A dimethoxyflavanone that is (2S)-(-)-kurarinone in which the hydroxy group at position 2 is replaced by a methoxy group. Isolated from the roots of Sophora flavescens, it exhibits cytotoxicity against human myeloid leukemia HL-60 cells. (2S)-2'-Methoxykurarinone, a compound isolated from the roots of Sophora flavescens, has anti-inflammatory, antipyretic, antidiabetic, and antineoplastic effects. (2S)-2'-Methoxykurarinone (MK) inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. (2S)-2'-Methoxykurarinone (MK) displays cytotoxic activity against human myeloid leukemia HL-60 cells[1][2]. (2S)-2'-Methoxykurarinone, a compound isolated from the roots of Sophora flavescens, has anti-inflammatory, antipyretic, antidiabetic, and antineoplastic effects. (2S)-2'-Methoxykurarinone (MK) inhibits osteoclastogenesis and bone resorption through down-regulation of RANKL signaling. (2S)-2'-Methoxykurarinone (MK) displays cytotoxic activity against human myeloid leukemia HL-60 cells[1][2].
9alpha-Acetoxymelnerin B
[3aR-(3aalpha,4aalpha,5alpha,7abeta,9abeta)]-5-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3a,4,4a,5,6,7,7a,9a-octahydro-5,8-dimethyl-3-methylene-azuleno[6,5-b]furan-2(3H)-one
28-Deoxonimbolide
28-deoxonimbolide is a limonoid isolated from Azadirachta indica. It has a role as an antineoplastic agent and a plant metabolite. It is an organic heteropentacyclic compound, a cyclic terpene ketone, an enone, a member of furans, a limonoid and a methyl ester. 28-Deoxonimbolide is a natural product found in Azadirachta indica with data available. A limonoid isolated from Azadirachta indica.
Absinthifolide
4,8,12-Tris(acetyloxy)-10-[(acetyloxy)methyl]-2,6-dimethyl-2,6,10-dodecatrienal
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] (Z)-4-acetyloxy-2-(hydroxymethyl)but-2-enoate
(7R,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,3-dimethoxy-8-O-4-neolignan
(R)-Oct-1-en-3-yl O-??-L-arabinopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
1-<4-O-(2-hydroxy-1-hydroxymethylethyl)-3-methoxyphenyl>-2-<4-(1-propanol)-3-methoxyphenyl>-propane-1,3-diol|1-[4-O-(2-hydroxy-1-hydroxymethylethyl)-3-methoxyphenyl]-2-[4-(1-propanol)-3-methoxyphenyl]-propane-1,3-diol
lespeflorin G3
A member of the class of pterocarpans that is (6aR,11aR)-pterocarpan substituted by hydroxy groups at positions 3 and 8, methoxy groups at positions 1 and 9 and prenyl groups at positions 2 and 10. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
1,3-Di(4-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene-2,7-diol
2-(3,4-dimethoxyphenyl)-6-[(2E)-3,7-dimethylocta-2,6-dien-1-yl]-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one|6-geranyl-5,7-dihydroxy-3,4-dimethoxyflavanone
Tetra-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetrio
ochrindole A
A bisindole alkaloid that is phenol bearing a 3,3-dimethylallyl group at position 4, two methoxy groups at positions 3 and 6, and two indol-3-yl groups at positions 2 and 5. It is a natural product isolated from the sclerotia of Aspergillus orbraceus, with moderate activity against some insects, as well as Gram-positive bacteria.
(1R*,4R*,5R*,8S*,10R*)-1,4-Epoxy-1-ethoxy-5-hydroxy-8-methacryloxy-13-acetoxygermacra-5E,7(11)-dien-6,12-olide
(2S)-5,7,4-trihydroxy-2-methoxy-8,5-di(3-methyl-2-butenyl)-6-methylflavanone
4-hydroxy-5,7-dimethoxy-6,3-diprenylisoflavanquinone|licoriquinone A
1alpha-(3-furanoyloxy)-9beta-benzoyloxy-dihydro-beta-agarofuran
(3R)-5,8-di-(gamma,gamma-dimethylallyl)-2,5-dihydroxyl-4,7-dimethoxyl-isoflavanone
5,3?-dihydroxy-7,4?-dimethoxy-6,8-dimethylallylflavanone|prenylutiline
1,3,5,7-tetrahydroxy-2-isoprenyl-8-geranylxanthone|cratoxyarborenone A
Fluocinolone Acetonide
C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid S - Sensory organs > S02 - Otologicals > S02B - Corticosteroids > S02BA - Corticosteroids D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8722; ORIGINAL_PRECURSOR_SCAN_NO 8717 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8755; ORIGINAL_PRECURSOR_SCAN_NO 8753 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8759; ORIGINAL_PRECURSOR_SCAN_NO 8757 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8810; ORIGINAL_PRECURSOR_SCAN_NO 8805 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8806; ORIGINAL_PRECURSOR_SCAN_NO 8804 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8815; ORIGINAL_PRECURSOR_SCAN_NO 8813 CONFIDENCE standard compound; INTERNAL_ID 2402
C23H32O9_Cyclohexaneacetic acid, 6-[4-(acetyloxy)-3-hydroxy-2-methylene-1-oxobutoxy]-4-ethenyl-2-hydroxy-3-[1-(hydroxymethyl)ethenyl]-4-methyl-alpha-methylene-, methyl ester
C23H32O9_D-Glucitol, 1,5-anhydro-1-C-[2,6-dihydroxy-3-(methoxycarbonyl)-4-[(3Z,5Z)-3,5-nonadien-1-yl]phenyl]-, (1S)
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 4-acetyloxy-3-hydroxy-2-methylidenebutanoate
methyl 2,4-dihydroxy-6-[(3Z,5Z)-nona-3,5-dienyl]-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzoate
Ala Cys Phe Ile
Ala Cys Phe Leu
Ala Cys Ile Phe
Ala Cys Leu Phe
Ala Glu His Pro
Ala Glu Pro His
Ala Phe Cys Ile
Ala Phe Cys Leu
Ala Phe Ile Cys
Ala Phe Leu Cys
Ala His Glu Pro
Ala His Pro Glu
Ala Ile Cys Phe
Ala Ile Phe Cys
Ala Leu Cys Phe
Ala Leu Phe Cys
Ala Leu Tyr Ser
Ala Pro Glu His
Ala Pro His Glu
Ala Ser Ile Tyr
Ala Ser Leu Tyr
Ala Ser Tyr Ile
Ala Ser Tyr Leu
Ala Thr Val Tyr
Ala Thr Tyr Val
Ala Val Thr Tyr
Ala Val Tyr Thr
Ala Tyr Leu Ser
Ala Tyr Ser Ile
Ala Tyr Ser Leu
Ala Tyr Thr Val
Ala Tyr Val Thr
Cys Ala Phe Ile
Cys Ala Phe Leu
Cys Ala Ile Phe
Cys Ala Leu Phe
Cys Phe Ala Ile
Cys Phe Ala Leu
Cys Phe Ile Ala
Cys Phe Leu Ala
Cys Ile Ala Phe
Cys Ile Phe Ala
Cys Leu Ala Phe
Cys Leu Phe Ala
Glu Ala His Pro
Glu Ala Pro His
Glu His Ala Pro
Glu His Pro Ala
Glu Pro Ala His
Glu Pro His Ala
Phe Ala Cys Ile
Phe Ala Cys Leu
Phe Ala Ile Cys
Phe Ala Leu Cys
Phe Cys Ala Ile
Phe Cys Ala Leu
Phe Cys Ile Ala
Phe Cys Leu Ala
Phe Gly Met Val
Phe Gly Val Met
Phe Ile Ala Cys
Phe Ile Cys Ala
Phe Ile Ser Ser
Phe Leu Ala Cys
Phe Leu Cys Ala
Phe Leu Ser Ser
Phe Met Gly Val
Phe Met Val Gly
Phe Ser Ile Ser
Phe Ser Leu Ser
Phe Ser Ser Ile
Phe Ser Ser Leu
Phe Ser Thr Val
Phe Ser Val Thr
Phe Thr Ser Val
Phe Thr Val Ser
Phe Val Gly Met
Phe Val Met Gly
Phe Val Ser Thr
Phe Val Thr Ser
Gly Phe Met Val
Gly Phe Val Met
Gly Ile Thr Tyr
Gly Ile Tyr Thr
Gly Leu Thr Tyr
Gly Leu Tyr Thr
Gly Met Phe Val
Gly Met Val Phe
Gly Thr Ile Tyr
Gly Thr Leu Tyr
Gly Thr Tyr Ile
Gly Thr Tyr Leu
Gly Val Phe Met
Gly Val Met Phe
Gly Tyr Ile Thr
Gly Tyr Leu Thr
Gly Tyr Thr Ile
Gly Tyr Thr Leu
His Ala Glu Pro
His Ala Pro Glu
His Glu Ala Pro
His Glu Pro Ala
His Pro Ala Glu
His Pro Glu Ala
Ile Ala Cys Phe
Ile Ala Phe Cys
Ile Ala Ser Tyr
Ile Ala Tyr Ser
Ile Cys Ala Phe
Ile Cys Phe Ala
Ile Phe Ala Cys
Ile Phe Cys Ala
Ile Phe Ser Ser
Ile Gly Thr Tyr
Ile Gly Tyr Thr
Ile Ser Ala Tyr
Ile Ser Phe Ser
Ile Ser Ser Phe
Ile Ser Tyr Ala
Ile Thr Gly Tyr
Ile Thr Tyr Gly
Ile Tyr Ala Ser
Ile Tyr Gly Thr
Ile Tyr Ser Ala
Ile Tyr Thr Gly
Leu Ala Cys Phe
Leu Ala Phe Cys
Leu Ala Ser Tyr
Leu Ala Tyr Ser
Leu Cys Ala Phe
Leu Cys Phe Ala
Leu Phe Ala Cys
Leu Phe Cys Ala
Leu Phe Ser Ser
Leu Gly Thr Tyr
Leu Gly Tyr Thr
Leu Ser Ala Tyr
Leu Ser Phe Ser
Leu Ser Ser Phe
Leu Ser Tyr Ala
Leu Thr Gly Tyr
Leu Thr Tyr Gly
Leu Tyr Ala Ser
Leu Tyr Gly Thr
Leu Tyr Ser Ala
Leu Tyr Thr Gly
Met Phe Gly Val
Met Phe Val Gly
Met Gly Phe Val
Met Gly Val Phe
Met Val Phe Gly
Met Val Gly Phe
Pro Ala Glu His
Pro Ala His Glu
Pro Glu Ala His
Pro Glu His Ala
Pro His Ala Glu
Pro His Glu Ala
Ser Ala Ile Tyr
Ser Ala Leu Tyr
Ser Ala Tyr Ile
Ser Ala Tyr Leu
Ser Phe Ile Ser
Ser Phe Leu Ser
Ser Phe Ser Ile
Ser Phe Ser Leu
Ser Phe Thr Val
Ser Phe Val Thr
Ser Ile Ala Tyr
Ser Ile Phe Ser
Ser Ile Ser Phe
Ser Ile Tyr Ala
Ser Leu Ala Tyr
Ser Leu Phe Ser
Ser Leu Ser Phe
Ser Leu Tyr Ala
Ser Ser Phe Ile
Ser Ser Phe Leu
Ser Ser Ile Phe
Ser Ser Leu Phe
Ser Thr Phe Val
Ser Thr Val Phe
Ser Val Phe Thr
Ser Val Thr Phe
Ser Tyr Ala Ile
Ser Tyr Ala Leu
Ser Tyr Ile Ala
Ser Tyr Leu Ala
Thr Ala Val Tyr
Thr Ala Tyr Val
Thr Phe Ser Val
Thr Phe Val Ser
Thr Gly Ile Tyr
Thr Gly Leu Tyr
Thr Gly Tyr Ile
Thr Gly Tyr Leu
Thr Ile Gly Tyr
Thr Ile Tyr Gly
Thr Leu Gly Tyr
Thr Leu Tyr Gly
2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-7-hydroxy- glucuronide
Thr Ser Phe Val
Thr Ser Val Phe
Thr Val Ala Tyr
Thr Val Phe Ser
Thr Val Ser Phe
Thr Val Tyr Ala
Thr Tyr Ala Val
Thr Tyr Gly Ile
Thr Tyr Gly Leu
Thr Tyr Ile Gly
Thr Tyr Leu Gly
Thr Tyr Val Ala
Val Ala Thr Tyr
Val Ala Tyr Thr
Val Phe Gly Met
Val Phe Met Gly
Val Phe Ser Thr
Val Phe Thr Ser
Val Gly Phe Met
Val Gly Met Phe
Val Met Phe Gly
Val Met Gly Phe
Val Ser Phe Thr
Tyr Gly Thr Leu
6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, (6b,11b,16b,17a)-Androsta-1,4-diene-17-c
8-Butanoylneosolaniol
8-Isobutanoylneosolaniol
3-Hydroxy-4-(3-hydroxy-1-propen-2-yl)-2-(3-methoxy-3-oxo-1-propen-2-yl)-5-methyl-5-vinylcyclohexyl 4-acetoxy-3-hydroxy-2-methylenebutanoate
25,26,27,28-tetrahydroxycalix[4]arene monoethyl ether
Eprazinone 2HCl
D019141 - Respiratory System Agents > D005100 - Expectorants Eprazinone dihydrochloride is a gent with mucolytic, secretolytic, antitussive, and bronchial antispasmodic properties. Eprazinone dihydrochloride is a neurokinin 1 receptor (NK1R) ligand. Eprazinone dihydrochloride has the potential for chronic bronchitis treatment that improved pulmonary function and arterial partial pressure of oxygen[1][2].
2-[4-[2-[4-[2-(2-methylprop-2-enoyloxy)ethoxy]phenyl]propan-2-yl]phenoxy]ethyl 2-methylprop-2-enoate
(6A,11B,16A,17A)-6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIENE-17-CARBOXYLIC ACID
3,3-[Oxybis(2,1-ethanediyloxy)]bis-1-propanamine (2Z)-2-butenedioate (1:2)
C10H24N2O3.2(C4H4O4) (452.2006)
Dexamethasone Acetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents
2-tert-butylcyclopenta-1,3-diene,carbanide,hafnium(4+)
3-(8-((Dimethylamino)methyl)-6,7,8,9-tetrahydropyrido(1,2-a)indol-10-yl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
1-{2-[(4-Chlorophenyl)amino]-2-oxoethyl}-N-(1-isopropylpiperidin-4-YL)-1H-indole-2-carboxamide
N-((1S)-1-(3-Chloro-1-naphthalenyl)ethyl)-2-(4-(4-fluorophenyl)-1-methyl-4-P iperidinyl)-N-methylacetamide
1-Benzyl-2,3-dimethylguanidinium sulphate (2:1)
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
phosphono [(2E,7S,10E)-3,7,11,15-tetramethylhexadeca-2,10,14-trienyl] hydrogen phosphate
Bethanidine Sulfate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
bis{N-[(benzylamino)(methylamino)methylidene]methanaminium} sulfate
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents
Arisugacin C
An organic heterotetracyclic compound that is 4,4,6a,12b-tetramethyl-1,4a,5,6,6a,12,12a,12b-octahydro-2H,11H-benzo[f]pyrano[4,3-b]chromene-3,11(4H)-dione substituted at position 4a by a hydroxy and and at position 9 by 4-methoxyphenyl group (the 4aS,6aR,12aR,12bR stereoisomer). Isolated from the culture broth of Penicillium, it acts as a selective inhibitor of acetylcholinesterase.
[2-Methoxy-5-[[4-(4-methylphenyl)-1-phthalazinyl]amino]phenyl]-(1-piperidinyl)methanone
3-[[(1-tert-butyl-5-tetrazolyl)methyl-(thiophen-2-ylmethyl)amino]methyl]-6-ethoxy-1H-quinolin-2-one
15,16-epoxy-8alpha-(benzoyloxy)methyl-2R-hydroxycleroda-3,13(16),14-trien-18-oic acid, (rel)-
A natural product found in Dodonaea polyandra.
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(2-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
(1R)-N-(2-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoate
[4-[Hydroxy(diphenyl)methyl]-1-triazolyl]-[4-(phenylmethyl)-1-piperidinyl]methanone
(1S,2S,4R,8R,9S,11R,12S,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
20-oxoleukotriene E4(1-)
A leukotriene anion that is the conjugate base of leukotriene E4 obtained by deprotonation of the two carboxy groups and protonation of the cysteinyl alpha-amino group; major species at pH 7.3.
(-)-(S)-B-973B
(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1]. (-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].
KT172
KT172 is a DAGLβ inhibitor with an IC50 value of 11 nM. KT172 can be used for the research of metabolic and inflammatory[1].
7-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-5-methoxy-8-[5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
4,8-bis(acetyloxy)-2-[2-(acetyloxy)ethylidene]-6,10-dimethyl-11-oxoundeca-5,9-dien-1-yl acetate
(2s)-5,7-dihydroxy-2-[4-hydroxy-2-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-6-methyl-8-(3-methylbut-2-en-1-yl)-2,3-dihydro-1-benzopyran-4-one
2-(oct-1-en-3-yloxy)-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2s)-5-hydroxy-2-(2-hydroxy-4-methoxyphenyl)-7-methoxy-6-[(2s)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl]-2,3-dihydro-1-benzopyran-4-one
(2r)-7-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-5,10-dihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
13-[(benzoyloxy)methyl]-1-hydroxy-8-isopropyl-2-methyl-15-oxatetracyclo[10.2.1.0²,¹⁰.0⁵,⁹]pentadeca-8,13-diene-5-carboxylic acid
[(2r,3s,4s,5r,6r)-6-{[(3as,8ar,9ar)-8a-methyl-3-methylidene-2-oxo-3ah,4h,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-5-yl]methoxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
(2s)-9-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5,7,10-trihydroxy-2-methyl-4-oxo-1,3-dihydroanthracen-2-yl acetate
(2e,4r,6e,8r,10z)-8,12-bis(acetyloxy)-10-[(acetyloxy)methyl]-2,6-dimethyl-1-oxododeca-2,6,10-trien-4-yl acetate
2'-methoxykurarinone
{"Ingredient_id": "HBIN005915","Ingredient_name": "2'-methoxykurarinone","Alias": "NA","Ingredient_formula": "C27H32O6","Ingredient_Smile": "CC(=CCC(CC1=C2C(=C(C=C1O)OC)C(=O)CC(O2)C3=C(C=C(C=C3)O)OC)C(=C)C)C","Ingredient_weight": "452.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT16513","TCMID_id": "13978","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "133561937","DrugBank_id": "NA"}